--- title: Last Participant Enrolled in Study of Infant Microbiome and Immune Health description: Prospective study designed to assess the immunological effect of a specific B. infantis strain on the incidence of atopic dermatitis, one of the most prevalent pediatric allergic diseases. image: https://www.infinanthealth.com/hubfs/Microsite/images/infinant-learning-center-feet-grey.jpg --- [![Infinant_logo_K_no_mark_new](https://www.infinanthealth.com/hs-fs/hubfs/Infinant_logo_K_no_mark_new.png?width=250&height=125&name=Infinant_logo_K_no_mark_new.png) ![Infinant_logo_K_no_mark_new](https://www.infinanthealth.com/hs-fs/hubfs/Infinant_logo_K_no_mark_new.png?width=250&height=125&name=Infinant_logo_K_no_mark_new.png)](https://www.infinanthealth.com) [![Infinant_logo_K_no_mark_new](https://www.infinanthealth.com/hs-fs/hubfs/Infinant_logo_K_no_mark_new.png?width=250&height=125&name=Infinant_logo_K_no_mark_new.png)](https://www.infinanthealth.com) - [Our Story](https://www.infinanthealth.com/about/our-story) - [Our Science](https://www.infinanthealth.com/about/our-science) - [For Investors](https://www.infinanthealth.com/for-investors) - [Publications](https://www.infinanthealth.com/publications) - [Clinical Trials](https://www.infinanthealth.com/clinicaltrials) - [Our Team](https://www.infinanthealth.com/about/our-teams) - [In The Press](https://www.infinanthealth.com/in-the-press) - [Contact Us](https://www.infinanthealth.com/contact-us) - [Our Story](https://www.infinanthealth.com/about/our-story) - [Our Science](https://www.infinanthealth.com/about/our-science) - [For Investors](https://www.infinanthealth.com/for-investors) - [Publications](https://www.infinanthealth.com/publications) - [Clinical Trials](https://www.infinanthealth.com/clinicaltrials) - [Our Team](https://www.infinanthealth.com/about/our-teams) - [In The Press](https://www.infinanthealth.com/in-the-press) - [Contact Us](https://www.infinanthealth.com/contact-us) ![Infinant Health](https://www.infinanthealth.com/hubfs/circle-1-720x720.png) By **Infinant Health** on February 15, 2023 [Featured](https://www.infinanthealth.com/press/tag/featured) # Last Participant Enrolled in Study of Infant Microbiome and Immune Health #### Prospective study designed to assess the immunological effect of a specific *B. infantis* strain on the incidence of atopic dermatitis, one of the most prevalent pediatric allergic diseases.   Infinant Health, Inc, a company focused on improving infant health through the gut microbiome, today announced the enrollment of the final participant in a study focused on the infant microbiome and immune health.   The study, which has been conducted in Finland by Johnson & Johnson Consumer Inc. in collaboration with Infinant Health, investigates the clinical and immunological effects of supplementation with a live *B. infantis* strain in healthy breastfed infants at risk of developing atopic dermatitis (AD), one of the most prevalent pediatric allergic diseases.  “Infinant Health is committed to improving the lifelong health of all infants through life-changing science and innovation to ensure all babies have a vital start to life,” said Infinant Health CEO, Mike Johnson. “Today, up to 20% of US children are affected by atopic dermatitis, typically the first manifestation of the ‘atopic march’, a progression of allergic conditions, including food allergy. Studying the infant microbiome to inform potential solutions for this immune health issue is critical as we look to provide a healthier future for all children.”   The study has enrolled over 270 infants in Finland overcoming significant pandemic-related recruitment challenges and will assess clinical and immunological outcomes of each subject over the course of 2 years.  “As a prospective placebo-controlled randomized study, this is an important step towards validating the direct impact of *B. infantis* on the infant microbiome and its relationship to overall immune health,” said Infinant Health Global Medical & Scientific Advisor, Karl Sylvester.  To learn more about the study, visit the following link at ClinicalTrials.gov: [A Study of a Probiotic Food Supplement Containing B. Infantis (EVC001) in Healthy Breastfed Infants at Risk of Developing Atopic Dermatitis - Full Text View - ClinicalTrials.gov](https://www.clinicaltrials.gov/ct2/show/NCT04662619?cond=Atopic+Dermatitis+Eczema&lead=JOHNSON+%26+jOHNSON&age=0&draw=2&rank=8)  **ABOUT INFINANT HEALTH, INC **   Infinant Health, Inc ("Infinant Health"), previously known as Evolve Biosystems, is a privately held company committed to changing the trajectory of human health through the development of healthy immune systems via the infant microbiome. Infinant Health is building a product pipeline to optimize infant health.  Investors in the company include the Bill and Melinda Gates Foundation, Johnson & Johnson, Cargill, and other leading institutions. Learn more about [Infinant here](https://www.infinanthealth.com/)[.](https://www.infinanthealth.com/)    Published by **Infinant Health** February 15, 2023 ![Infinant Health](https://www.infinanthealth.com/hubfs/circle-1-720x720.png) [![](https://www.infinanthealth.com/hubfs/IH-Header-Home-Eye-2048x1370.jpg) Read More](https://www.infinanthealth.com/press/what-we-can-learn-babies-gut-microbiomes) [Featured](https://www.infinanthealth.com/press/tag/featured) By **Infinant Health** on February 15, 2023 ### [What We Can Learn from Babies’ Gut Microbiomes](https://www.infinanthealth.com/press/what-we-can-learn-babies-gut-microbiomes) [![](https://www.infinanthealth.com/hubfs/infinant-health-our-story.jpg) Read More](https://www.infinanthealth.com/press/infinant-health-announces-mike-johnson-as-chief-executive-officer) [Featured](https://www.infinanthealth.com/press/tag/featured) By **Infinant Health** on February 15, 2023 ### [Infinant Health Announces Mike Johnson as Chief Executive Officer](https://www.infinanthealth.com/press/infinant-health-announces-mike-johnson-as-chief-executive-officer) [![](https://www.infinanthealth.com/hubfs/infinant-health-our-story.jpg) Read More](https://www.infinanthealth.com/press/infinant-health-and-connected-world-without-disease-accelerator-cwwda-announce-global-strategic-partnership) [Featured](https://www.infinanthealth.com/press/tag/featured) By **Infinant Health** on February 15, 2023 ### [Infinant Health and Connected World Without Disease Accelerator (CWWDA) Announce Global Strategic Partnership](https://www.infinanthealth.com/press/infinant-health-and-connected-world-without-disease-accelerator-cwwda-announce-global-strategic-partnership) [![Infinant White](https://www.infinanthealth.com/hs-fs/hubfs/Infinant%20White.png?width=180&height=90&name=Infinant%20White.png)](https://www.infinanthealth.com) **Contact Us At:** **[customerservice@infinanthealth.com](mailto:customerservice@infinanthealth.com?subject=Evivo%20Customer%20Support%20Request)** 2535 Capitol Oaks Dr, Suite 130 Sacramento, CA 95833 ([Map](https://goo.gl/maps/G78CcEdeMsa7yoLy9)) - - - - - - [Company](https://www.infinanthealth.com/about/our-story) - [Our Story](https://www.infinanthealth.com/about/our-story) - [Our Science](https://www.infinanthealth.com/about/our-science) - [Our Team](https://www.infinanthealth.com/about/our-teams) - [Contact Us](https://www.infinanthealth.com/contact-us) ©2026 Infinant Health Inc   All rights reserved.   [Privacy Policy](https://www.infinanthealth.com/privacy)   |   [Terms of Service](https://www.infinanthealth.com/terms-of-service) ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Infinant Health", "url" : "https://www.infinanthealth.com/press/author/infinant-health" }, "dateModified" : "2023-02-15T11:45:00.466Z", "datePublished" : "2023-02-15T11:45:00.000Z", "headline" : "Last Participant Enrolled in Study of Infant Microbiome and Immune Health", "image" : [ "https://www.infinanthealth.com/hubfs/Microsite/images/infinant-learning-center-feet-grey.jpg" ], "mainEntityOfPage" : { "@id" : "https://www.infinanthealth.com/press/last-participant-enrolled-in-study-of-infant-microbiome-and-immune-health", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://www.infinanthealth.com/hubfs/Infinant_logo_RGB_Black_300-1.png" }, "name" : "Infinant Health" } } ```